These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 17224185)

  • 21. Cognitive impairment in late life schizophrenia and bipolar I disorder.
    Meesters PD; Schouws S; Stek M; de Haan L; Smit J; Eikelenboom P; Beekman A; Comijs H
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):82-90. PubMed ID: 22407730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.
    Mausbach BT; Harvey PD; Pulver AE; Depp CA; Wolyniec PS; Thornquist MH; Luke JR; McGrath JA; Bowie CR; Patterson TL
    Bipolar Disord; 2010 Feb; 12(1):45-55. PubMed ID: 20148866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved.
    Solé B; Jiménez E; Torrent C; Del Mar Bonnin C; Torres I; Reinares M; Priego Á; Salamero M; Colom F; Varo C; Vieta E; Martínez-Arán A
    Bipolar Disord; 2016 May; 18(3):288-99. PubMed ID: 27112120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological functioning in bipolar disorder and schizophrenia.
    Schretlen DJ; Cascella NG; Meyer SM; Kingery LR; Testa SM; Munro CA; Pulver AE; Rivkin P; Rao VA; Diaz-Asper CM; Dickerson FB; Yolken RH; Pearlson GD
    Biol Psychiatry; 2007 Jul; 62(2):179-86. PubMed ID: 17161829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis.
    Jenkins LM; Bodapati AS; Sharma RP; Rosen C
    J Clin Exp Neuropsychol; 2018 Feb; 40(1):84-94. PubMed ID: 28562181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
    Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis.
    Bowie CR; Best MW; Depp C; Mausbach BT; Patterson TL; Pulver AE; Harvey PD
    Bipolar Disord; 2018 Nov; 20(7):604-613. PubMed ID: 29777563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year follow-up of cognitive impairment in older adults with bipolar disorder.
    Schouws SN; Comijs HC; Dols A; Beekman AT; Stek ML
    Bipolar Disord; 2016 Mar; 18(2):148-54. PubMed ID: 26961121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses.
    Metzler S; Dvorsky D; Wyss C; Müller M; Gerstenberg M; Traber-Walker N; Walitza S; Theodoridou A; Rössler W; Heekeren K
    Psychol Med; 2015 Jul; 45(10):2123-34. PubMed ID: 25640248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia.
    Barrett SL; Mulholland CC; Cooper SJ; Rushe TM
    Br J Psychiatry; 2009 Jul; 195(1):67-72. PubMed ID: 19567899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
    Demily C; Jacquet P; Marie-Cardine M
    Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.
    Maziade M; Rouleau N; Gingras N; Boutin P; Paradis ME; Jomphe V; Boutin J; Létourneau K; Gilbert E; Lefebvre AA; Doré MC; Marino C; Battaglia M; Mérette C; Roy MA
    Schizophr Bull; 2009 Sep; 35(5):919-30. PubMed ID: 18550590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in severe mental illness in the Paisa population: a case-control study.
    Service SK; Vargas Upegui C; Castaño Ramírez M; Port AM; Moore TM; Munoz Umanes M; Agudelo Arango LG; Díaz-Zuluaga AM; Melo Espejo J; López MC; Palacio JD; Ruiz Sánchez S; Valencia J; Teshiba TM; Espinoza A; Olde Loohuis L; De la Hoz Gomez J; Brodey BB; Sabatti C; Escobar JI; Reus VI; Lopez Jaramillo C; Gur RC; Bearden CE; Freimer NB
    Lancet Psychiatry; 2020 May; 7(5):411-419. PubMed ID: 32353276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Set shifting and reversal learning in patients with bipolar disorder or schizophrenia.
    McKirdy J; Sussmann JE; Hall J; Lawrie SM; Johnstone EC; McIntosh AM
    Psychol Med; 2009 Aug; 39(8):1289-93. PubMed ID: 19105856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
    Kaladjian A; Azorin JM; Pomietto P; Corréard N; Belzeaux R; Adida M
    Encephale; 2012 Dec; 38 Suppl 3():S81-4. PubMed ID: 23279993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.